カテゴリー
AAV BIOLOGICS efficacy safety

[Data Link] Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI – ID4540 [2019/12/19]

[Data Link] Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI – ID4540 [2019/12/19]
Post Views: 69

Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI

関連記事:

[Bio-Edu] rAAVの臨床投与量 – ID1176 [2019/07/31] [Bio-rAAV] アデノ随伴ウイルス(AAV)ベクターを使用する意義(特徴)と製造概要 – △ID1862 [2019/09/06] [Data Link] rAAV vector/遺伝子治療薬に関する文献調査 [~2020/08/24] – △ID2033 [2019/09/13] [rAAV-Edu] POROS CaptureSelect (AAV精製 resin) の性能とAEXによるfull/emptyの分離 – ID2271 [2019/09/18] 気になる企業 – Creative Biolabs Inc. はcGMP製造もできるCRO – △ID2413 [2020/05/21] [rAAV-Production] – 治療用AAV Vector製造 – 考慮事項 – SM-ID12844 [2020/10/14]

用語の解説リンク、関連投稿および広告
スポンサーリンク ID 7130582967

- 以下のツールに敬意を示します -
Support to AMP (Accelerated Mobile Pages) by official AMP plugin for WordPress, and compatible powered by
Post viewing : Flex Posts - Widget and Gutenberg Block